Main Article Content

Abstract

Because of technology developments, the ECG yields improved outcomes in the realm of biomedical science and research. The Electrocardiogram reveals basic the heart's electrical activity. Early detection of aberrant heart disorders is crucial for diagnosing cardiac problems and averting sudden cardiac deaths. Measurements on an electrocardiogram (ECG) among people with comparable cardiac issues are essentially equal. Analyzing the Electrocardiogram characteristics can help predict abnormalities. Medical professionals presently base the preponderance of their Electrocardiogram diagnosis on their unique particular areas of expertise, which places a substantial load on their shoulders and reduces their performance. The use of technology that automatically analyses ECGs as hospital personnel performs their duties will be advantageous. A suitable algorithm must be able to categories Input signal with uncertain awesome feature on just how much they approximate Input signal having known characteristics in order to speed up the identification of heart illnesses. A possibility of identifying a tachycardia is raised if this predictor can reliably recognize connections, and this technique may be helpful in lab settings. To accurately diagnose myocardial illness, a powerful machine learning technique should be used. Through using recommended method, the effectiveness of cardiovascular disease identification using ECG dataset was evaluated. The reliability, sensitivities, and validity obtained using the Svm algorithm were 99.314%, 97.60%, and 97.60% respectively.

Keywords

Machine Learning Cardiovascular Disease Heart Disease Computer Science

Article Details

How to Cite
[1]
S. Pandey, “The Cardiovascular Disease Prediction Using Machine Learning ”, bit-cs, vol. 4, no. 1, pp. 24-27, Jan. 2023.

References

  1. P. McSharry, G. Clifford, L. Tarassenko, Method for generating an artificial RRtachogram of a typical healthy human over 24-hours, Comput. Cardiol. 29(2002) 225–228.
  2. S. Jayalalitha, D. Susan, Shalini Kumari and B. Archana, “K-nearest Neighbour Method of Analysing the ECG Signal (To find out the Different Disorders Related to Heart)”, Journal of Applied Sciences, 14: 1628-1632
  3. Romiti S, Vinciguerra M, Saade W, Anso Cortajarena I, Greco E. Artificial Intelligence (AI) and Cardiovascular Diseases: An Unexpected Alliance. Cardiol Res Pract. 2020 Jun 27;2020:4972346.
  4. Mamun, M.M.R.K. Significance of Features from Biomedical Signals in Heart Health Monitoring. BioMed 2022, 2, 391-408.
  5. Energy Fuels 2022, 36, 13, 6626–6658 Publication Date:June 13, 2022
  6. Rokach, Lior & Maimon, Oded. (2005). Decision Trees. 10.1007/0-387-25465-X
  7. Han, J., and M. Kamber. 2011. Data Mining: Concepts and Techniques. 3rd ed. Burlington: Morgan Kaufmann.
  8. Joachims, T. 1998. Making large-scale SVM learning practical. Adv. Kernel Methods - Support Vector Learn, MIT Press.
  9. A. M. Shah et al., “Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction,” J. Am. Coll. Cardiol., vol. 74, no. 23, pp. 2858–2873, 2019.
  10. S. Horiuchi and J. P. Kneller, “What can be learned from a future supernova neutrino detection?,” J. Phys. G Nucl. Part. Phys., vol. 45, no. 4, p. 43002, 2018.
  11. M. A. Lancaster and M. Huch, “Disease modelling in human organoids,” Dis. Model. Mech., vol. 12, no. 7, p. dmm039347, 2019.
  12. S. J. Al’Aref et al., “Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging,” Eur. Heart J., vol. 40, no. 24, pp. 1975–1986, 2019.
  13. J. Yu, W. Ouyang, M. L. K. Chua, and C. Xie, “SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China,” JAMA Oncol., vol. 6, no. 7, pp. 1108–1110, 2020.
  14. J. Stehlik et al., “Continuous wearable monitoring analytics predict heart failure hospitalization: the LINK-HF multicenter study,” Circ. Hear. Fail., vol. 13, no. 3, p. e006513, 2020.
  15. A. A. Kulkarni, V. E. Vijaykumar, S. K. Natarajan, S. Sengupta, and V. S. Sabbisetti, “Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer,” Nanomedicine Nanotechnology, Biol. Med., vol. 12, no. 7, pp. 1853–1861, 2016.